BIO CEO & INVESTOR CONFERENCE 2020

Time:February 10-11, 2020

Country&Region: United States

Venue:Marriott Marquis Hotel

Organizer:Bio (Biotechnology Industry Organization)

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.

SUNDAY, FEBRUARY 10 (BIO EXECUTIVE LEADERSHIP COURSES—ADDED FEE)

1:00 PM – 5:30 PM

Improving Negotiations and Decision Making By Applying Game Theory

MONDAY, FEBRUARY 11

6:00 AM – 6:00 PM	Registration
6:30 AM – 8:00 AM	Continental Breakfast
6:30 AM – 6:00 PM	BIO One-on-One Partnering Desk
7:20 AM – 6:00 PM	Satellite BIO One-on-One Partnering Desk
7:30 AM - 5:30 PM	BIO One-on-One Partnering Hospitality Suite
7:30 AM - 6:00 PM	BIO One-on-One Partnering Meetings
9:00 AM - 11:30 AM	Company Presentations
9:00 AM - 9:55 AM	Reshaping Tumor Microenvironments via Immunotherapies
10:00 AM - 10:55 AM	Fireside Chat: Nancy Thornberry, CEO, Kallyope
11:00 AM - 11:55 AM	Advances in Neuromuscular Disease Treatments
11:45 AM - 1:00 PM	Boxed Lunches Available
12:00 PM - 12:44 PM	Fireside Chat: Geoff Meyerson, Managing Partner and Co-Founder, Locust Walk
1:30 PM - 2:25 PM	Navigating Payers’ Expectations for Value-Based Agreements
1:15 PM - 4:15 PM	Company Presentations
2:30 PM - 3:25 PM	Fireside Chat: Jinzi Wu, PhD, Founder, Chairman, and CEO, Ascletis Pharma Inc.
3:30 PM - 4:25 PM	Attacking Biological Mechanisms of Aging to Extend Healthspan
4:30 PM - 5:45 PM	Market Outlook - Leveraging Market Corrections for M&A or IPOs
6:00 PM - 7:00 PM	Welcome Reception

Tuesday, February 12

6:30 AM - 4:00 PM	Registration
6:30 AM - 8:00 AM	Continental Breakfast
6:30 AM - 5:30 AM	BIO One-on-One Partnering Desk
6:50 AM - 6:00 PM	Satellite BIO One-on-One Partnering Desk
7:00 AM – 5:00 PM	BIO One-on-One Partnering Hospitality Suite
7:00 AM – 5:30 PM	BIO One-on-One Partnering Meetings
9:00 AM – 11:30 AM	Company Presentations
9:00 AM – 9:55 AM	New Treatments for Diabetes and Obesity: Innovations for Chronic Diseases
10:00 AM - 10:55 AM	Fireside Chat: William Slattery, Partner, Deerfield; and Annette Grimaldi, Managin Director & Head of Life Sciences Investment Banking, BMO Captial Markets
11:00 AM - 11:55 AM	Policy Outlook—How Could the Trump Administration’s Drug Reimbursement Proposals Affect Medical Innovation?
11:45 AM – 1:00 PM	Boxed Lunches Available
12:00 PM - 12:55 PM	Fireside Chat: Roger Crystal, MD, Chief Executive Officer, Opiant Pharmaceuticals
1:15 PM – 3:45 PM	Company Presentations
1:00 PM - 1:55 PM	Regulatory Changes to Cross-Border Investments: CFIUS and Biotech Deals
2:00 PM - 2:55 PM	Removing Commercialization Barriers for New Antimicrobial Drugs
3:00 PM - 3:55 PM	Fireside Chat: Dr. Aoife M. Brennan, President and Chief Executive Officer and Chief Medical Officer, Synlogic, Inc.
4:00 PM - 4:55 PM	Are Record Levels of IPOs Still Disrupting M&A Deals?
5:00 PM - 6:00 PM	Closing Reception

Website:https://www.bio.org/events/bio-ceo-investor-conference

Previous:The 6th China International Silver Industry Exhibition

Next:China Dental Show (CDS)